Free Trial

kneat.com Q4 2023 Earnings Report

kneat.com logo
C$5.93 +0.18 (+3.13%)
(As of 12/20/2024 05:17 PM ET)

kneat.com EPS Results

Actual EPS
-C$0.03
Consensus EPS
-C$0.04
Beat/Miss
Beat by +C$0.01
One Year Ago EPS
N/A

kneat.com Revenue Results

Actual Revenue
$9.81 million
Expected Revenue
$9.43 million
Beat/Miss
Beat by +$380.00 thousand
YoY Revenue Growth
N/A

kneat.com Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

kneat.com Earnings Headlines

Why I'm telling friends to avoid gold stocks
Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."
Global Medical Devices Manufacturer Selects Kneat to Digitize Validation
See More kneat.com Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like kneat.com? Sign up for Earnings360's daily newsletter to receive timely earnings updates on kneat.com and other key companies, straight to your email.

About kneat.com

kneat.com (TSE:KSI), together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. Its platform is used in various applications, including document management, analytical instrument validation, method validation, commissioning and qualification, drawing management, utility and facility validation, cold chain validation, electronic logbook management, process validation, computer system validation, and cleaning validation. The company also provides professional services, including consulting, training, process mapping, project management, and other services. kneat.com, inc. is headquartered in Limerick, Ireland.

View kneat.com Profile

More Earnings Resources from MarketBeat

Upcoming Earnings